What happened
In September 2012, doctors in Tennessee found a rare fungal meningitis in a patient who had received a steroid injection for back pain. Within weeks, the cases spread across the country.
The steroid came from the New England Compounding Center, a pharmacy in Framingham, Massachusetts. Its vials were contaminated with mold. They had been shipped to clinics in 23 states and injected into patients’ spines.
Source: CDC, October 2013. Prosecutors later put the death toll at 76.
Investigators found the pharmacy had been operating like a drug factory while licensed as a pharmacy, shipping large batches without the safeguards a manufacturer must follow. Its owner, Barry Cadden, was later sentenced to 14½ years in federal prison (Justice Department).
What changed
In 2013, Congress passed the Drug Quality and Security Act. It split compounding pharmacies into two kinds, and the difference tells you who is watching the place that makes your medicine.
503A pharmacy
Makes medicine for one patient at a time
- Needs a prescription written for you
- Licensed and inspected mainly by state pharmacy boards
- The FDA inspects some, often after a complaint
503B outsourcing facility
Makes larger batches, often for clinics
- Registered with the FDA
- Must follow federal manufacturing rules
- Inspected by the FDA on a risk-based schedule
Neither kind makes FDA-approved drugs. Compounded medicines don’t go through FDA review for safety or effectiveness before you get them. That’s why checking the pharmacy matters.